Global Health (MEDANTA) is currently at an exciting juncture, trading at 999 and situated in the daily Drop Base Rally (DBR) zone. This zone has proven historical significance, marking the origin of the all-time high and breaking through previous resistance levels. The stock's recent achievement of hitting an all-time high just three days ago further validates the strength of this zone.
📈 Key Analysis Points 🚀
The stock is in a robust uptrend, evident from the recent all-time high.
The DBR zone, where it is currently positioned, played a pivotal role in the stock's impressive rally.
Entry at 999 is strategic, aligning with the stock's historical breakout point.
A stop loss at 972 ensures risk management, protecting against unexpected downturns.
Targets should be set at least two times the risk, with potential for higher gains through trailing stops.
The price retracement to test the breakout with low volume signals a lack of selling pressure, presenting a compelling buying opportunity.
📊Fundamental Analysis for Investors:
Global Health, a major player in India's private healthcare, boasts a robust financial profile. With a market cap of INR 26,821.26 Cr. and a PE ratio of 65.60, the company's Price to Book Value stands at 10.11, slightly below the industry average.
Financially, it's impressive, showcasing a 58.3% CAGR in profit over 5 years. Despite a 11.3% return on equity over the past 3 years, the company maintains a healthy balance sheet, low leverage, and no significant debt. Strong liquidity indicators include a Cash Conversion Cycle of -57.82 days and a current ratio of 3.52.
Despite a commendable 36.83% profit growth in the past 3 years, a 10.00% revenue growth poses a challenge. Trading at a high PE of 83.61 and an elevated EV/EBITDA of 49.44 demands careful consideration. However, the company's debt-free status, positive quarterly results, and a substantial operating cash flow of Rs 644.52 Cr. position it for potential growth.
In shareholding, stability is evident with a decrease in promoter shareholding offset by rising FII and DII shareholding, indicating institutional confidence. The absence of pledged shares adds another layer of financial prudence.
🌐 Educational Reminder 🌐 This analysis is for educational purposes only and not intended as a trading or investment recommendation. I am not a SEBI registered analyst.
Lastly, thank you for your support, your likes, and comments! 🚀💹
Remember: "The market is a device for transferring money from the impatient to the patient."
トレード稼働中
Medanta is currently trading at 1159, up more than 17% in just 16 days from our entry level. Trail your SL to ride a rally